Vascular endothelial growth factor: its prognostic, predictive, and therapeutic implications
- 1 November 2001
- journal article
- review article
- Published by Elsevier in The Lancet Oncology
- Vol. 2 (11), 667-673
- https://doi.org/10.1016/s1470-2045(01)00556-3
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Vascular Endothelial Growth Factor Receptor-1 and Neuropilin-2 Form ComplexesJournal of Biological Chemistry, 2001
- VEGF-D promotes the metastatic spread of tumor cells via the lymphaticsNature Medicine, 2001
- Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasisNature Medicine, 2001
- Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3Nature Medicine, 2001
- VEGF: an update on biological and therapeutic aspectsCurrent Opinion in Biotechnology, 2000
- Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cellsThe Lancet, 2000
- Clinical applications of angiogenic growth factors and their inhibitorsNature Medicine, 1999
- Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferonNature Medicine, 1999
- Soluble VEGF receptorsAngiogenesis, 1999
- Isolation of Putative Progenitor Endothelial Cells for AngiogenesisScience, 1997